CORRELATION BETWEEN GLYCOSYLATED HAEMOGLOBIN, LIPID PROFILE AND THYROID FUNCTION AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35 (Suppl 1):S64-71.

Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.       

Joshi SR, Parikh RM. India — Diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India 2007;55:323-4.        

Alzaid AA. Time to declare war on diabetes. Ann Saudi Med 1997;17(2):154-5.               

Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160(4):526-34.        

Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4) and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87(2):489-99.        

Celani MF, Bonati ME, Stucci N. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Diabetes Res 1994;27(1):15-25.   

Rai S, Kumar JA, Prajna K, et al. Thyroid function in type 2 diabetes mellitus and in diabetic nephropathy. J Clin Diagn Res 2013;7(8):1583-5.   

Somwaru LL, Arnold AM, Joshi N, et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009;94(4):1342-5.        

Vikhe VB, Kanitkar SA, Tamakuwala KK, et al. Thyroid dysfunction in patient with type 2 diabetes mellitus at tertiary care centre. Natl J Med Res 2013;3(4):377-80.   

Saha HR, Sarkar BC, Khan SA, et al. A comparative study of thyroid hormone and lipid status in diabetic and non-diabetic adults. Open Access Sci Rep 2012;1:1-5.               

Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clin Exp Med 2007;7(1):24-9.                        

Cappelli C, Rotondi M, Pirola I, et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 2009;32(9):1589-90.       

Udiong CE, Etukudoh MH, Essien OE. Thyroid hormones and glycemic indices in types 1 and 2 diabetes mellitus. J Med Lab Sci 2007;16(2):1192-5.